Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Ajooni Biotech

    Jump to

    • Ajooni Biotech Standalone December 2025 Net Sales at Rs 58.75 crore, up 72.63% Y-o-Y

    • Ajooni Biotech Standalone June 2025 Net Sales at Rs 31.27 crore, up 21.86% Y-o-Y

    • Ajooni Biotech Standalone September 2024 Net Sales at Rs 25.72 crore, up 32.06% Y-o-Y

    • Ajooni Biotech Standalone June 2024 Net Sales at Rs 25.66 crore, up 22.17% Y-o-Y

    • Ajooni Biotech Standalone March 2024 Net Sales at Rs 19.58 crore, down 52.54% Y-o-Y

    • Ajooni Biotech Standalone December 2023 Net Sales at Rs 20.05 crore, up 88.63% Y-o-Y

    • Ajooni Biotech Standalone September 2023 Net Sales at Rs 19.48 crore, up 89.28% Y-o-Y

    • Ajooni Biotech Standalone June 2023 Net Sales at Rs 21.00 crore, up 70.61% Y-o-Y

    • Ajooni Biotech Standalone March 2023 Net Sales at Rs 41.26 crore, up 101.13% Y-o-Y

    • Ajooni Biotech Standalone March 2023 Net Sales at Rs 41.26 crore, up 101.13% Y-o-Y

    • Ajooni Biotech Standalone December 2022 Net Sales at Rs 10.63 crore, down 44.89% Y-o-Y

    • Ajooni Biotech Standalone September 2022 Net Sales at Rs 10.29 crore, down 44.04% Y-o-Y

    • Ajooni Biotech Standalone June 2022 Net Sales at Rs 12.31 crore, down 22.31% Y-o-Y

    • Ajooni Biotech Standalone March 2022 Net Sales at Rs 20.51 crore, up 26.71% Y-o-Y

    • Ajooni Biotech Standalone December 2021 Net Sales at Rs 19.29 crore, up 49.42% Y-o-Y

    • Ajooni Biotech Standalone December 2021 Net Sales at Rs 19.29 crore, up 49.42% Y-o-Y

    • Ajooni Biotech Standalone September 2021 Net Sales at Rs 18.39 crore, up 51.87% Y-o-Y

    • Ajooni Biotech Standalone June 2021 Net Sales at Rs 15.85 crore, up 61.18% Y-o-Y

    • Ajooni Biotech Standalone March 2021 Net Sales at Rs 16.19 crore, up 24.97% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347